Vertex Signs a License Agreement with Obsidian Therapeutics to Discover Regulated Gene Editing Therapies
Shots: Obsidian to receive $75M in equity, up front, research milestones and is eligible to receive ~$1.3B as research, development, regulatory, and commercial milestones across […]